MBNL1 identified as a potential cancer drug target for a type of childhood leukemia
Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements. The ...
Aug 10, 2026
0
5
